NINA SHAH (SAN FRANCISCO)
CART IN MULTIPLE MYELOMA
Dept. of Hematology – Oncology, University of California San Francisco, San Francisco, USA
In this talk we will explore the evolution of immunotherapy in the practice of treating multiple
myeloma. We will touch on incorporation of immunotherapy in the front-line, early relapse and late
relapse phases of the disease. We will also briefly discuss developing immunotherapy modalities
that may be available in the future.
References
https://pubmed.ncbi.nlm.nih.gov/32325490/
https://pubmed.ncbi.nlm.nih.gov/32682484/
https://pubmed.ncbi.nlm.nih.gov/31042825/
